Nonmarket Strategies for Omnichannel Transformation in the Pharmaceutical Industry
Marketers are using nonmarket strategies to enhance understanding and awareness of omnichannel stakeholders and re-set the demand curve.
Despite the availability of digital channels and increasing investment in training, the life science industry's transformation to omnichannel seems slow. Nonmarket strategies, which involve engaging with all stakeholders and leveraging internal and external resources, are key to addressing these challenges. In this white paper, our experts explore how the use of societal marketing and storytelling are key to enhancing understanding and awareness of omnichannel strategies among stakeholders. Overall, successful nonmarket strategies can lead to a re-setting of the demand curve and pave the way for the industry's transformation.
Download the white paper to gain a deeper understanding of the significance of non-market strategies in the pharmaceutical industry's transition to an omnichannel strategy.
Related Content
Looking for exclusive insight?
